share_log

Calliditas Therapeutics Says Liver Disease Therapy Met Main Goal in Phase 2b Study

Calliditas Therapeutics Says Liver Disease Therapy Met Main Goal in Phase 2b Study

calliditas therapeutics表示,肝臟疾病治療在第20億階段研究中達到了主要目標。
MT Newswires ·  07/26 05:15

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論